SCHEMBL4455599

SCHEMBL4455599

CCCCCCCCCc1ccc(C)c(Cc2c(C)ccc(CCCCCCCCC)c2O)c1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.60
ALOX5 P09917 6/20 0.49
TP53 P04637 2/20 0.49
CYP3A4 P08684 2/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.49
KMT2A Q03164 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
PTGS2 P35354 5/20 0.45
ELANE P08246 2/20 0.43
CTSG P08311 2/20 0.43
LIPG Q9Y5X9 1/20 0.42
ESR1 P03372 2/20 0.42
ADRA2A P08913 2/20 0.42
ADORA3 P0DMS8 2/20 0.42
TACR2 P21452 2/20 0.42
SLC6A2 P23975 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5313081 0.93 TYR (0.64) TYRALOX5TP53CYP3A4MEN1
SCHEMBL28956820 0.93 TYR (0.64) TYRALOX5TP53CYP3A4MEN1
SCHEMBL1424910 0.93 TYR (0.64) TYRALOX5TP53CYP3A4MEN1
SCHEMBL1005151 0.85 TYR (0.53) TYRALOX5TP53CYP3A4MEN1
SCHEMBL11513062 0.85 TYR (0.68) TYRALOX5TP53CYP3A4MEN1
SCHEMBL11512804 0.85 TYR (0.68) TYRALOX5TP53CYP3A4MEN1
SCHEMBL28370319 0.84 TYR (0.66) TYRALOX5TP53CYP3A4MEN1
SCHEMBL5680424 0.84 TYR (0.66) TYRALOX5TP53CYP3A4MEN1
SCHEMBL10345469 0.82 TYR (0.74) TYRALOX5TP53CYP3A4MEN1
SCHEMBL1957156 0.82 TYR (0.74) TYRALOX5TP53CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4214035-A1 ROTATIONAL MOLDING COMPOSITION Nova Chemicals (International) S.A. (CH) 2023-07-26 EP disclosed
EP-4150001-A1 POLYETHYLENE HOMOPOLYMER COMPOSITIONS WITH BALANCED PROPERTIES Nova Chemicals (International) S.A. (CH) 2023-03-22 EP disclosed
EP-4133004-A1 HIGH DENSITY POLYETHYLENE FOR RIGID ARTICLES Nova Chemicals (International) S.A. (CH) 2023-02-15 EP disclosed
EP-4106971-A1 ROTOMOLDING COMPOSITION Nova Chemicals (International) S.A. (CH) 2022-12-28 EP disclosed
WO-2022058835-A1 ROTATIONAL MOLDING COMPOSITION NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) 2022-03-24 WO disclosed
US-20090203817-A1 STABILIZED SPANDEX COMPOSITIONS CYTEC TECHNOLOGY CORP. 2009-08-13 US disclosed
WO-2007120749-A1 STABILIZED SPANDEX COMPOSITIONS CYTEC TECHNOLOGY CORP. (US) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203817-A1 STABILIZED SPANDEX COMPOSITIONS SMCHD1, SMC1A, SI TYR 3376/4885ALOX5 2289/4885TP53 2168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.